In xenograft and syngeneic mouse models of this cancer type, TLR5 signaling activation via TLR5 agonists can initiate innate immunity and elicit potent anti-tumor responses that regulate tumor growth [40]. The gene discussed is TLR5; the disease is neoplasm.